UPDATE 2-Novartis sets sights on return to growth in 2018 By: Reuters: Company News April 25, 2017 at 05:20 AM EDT * Advances MS drug BAF312 filing date to 2018 from 2019 (Recasts to focus on growth outlook in 2018, adds analyst comments, details) Read More >> Related Stocks: Eli Lilly Gsk Plc ADR Novan Inc Rogers Corp